Related Experiment Videos

Transforming growth factor type beta (TGF beta) inhibits G1 to S transition, but not activation of human B

Insights

Type beta transforming growth factor (TGF beta) inhibits DNA synthesis in human B lymphocytes. This immune cell growth factor arrests cells in the G1 phase before transferrin receptor expression.

Area of Science:

  • Immunology
  • Cell Biology
  • Molecular Biology

Background:

  • Type beta transforming growth factor (TGF beta) is a polypeptide influencing cell growth.
  • B lymphocytes play a crucial role in the adaptive immune response.

Purpose of the Study:

  • To investigate the effect of TGF beta on human B lymphocyte proliferation.
  • To determine the specific cell cycle phase affected by TGF beta.

Main Methods:

  • Normal and neoplastic human B lymphocytes were stimulated to proliferate.
  • Cells were treated with TGF beta and analyzed for DNA synthesis and cell cycle parameters.
  • Key activation markers and gene expression were monitored.

Main Results:

  • TGF beta markedly inhibited DNA synthesis in stimulated B lymphocytes.
  • TGF beta did not significantly affect early to intermediate cell activation markers.
  • TGF beta blocked the induction of transferrin receptor expression, a late G1 event.

Conclusions:

  • TGF beta arrests human B lymphocytes in the middle to late G1 phase of the cell cycle.
  • The mechanism involves preventing progression to transferrin receptor expression.
  • TGF beta's inhibitory effect on B cell proliferation is cell cycle-specific.

Related Concept Videos